After Hours
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility.
Stocks Info
ARS Pharmaceuticals Inc is listed on the NASDAQ in the Healthcare sector while operating in the Biotechnology industry. The current market capitalization of ARS Pharmaceuticals Inc is $1.02B. A total of 2.28 million shares were traded on the day, compared to an average of 1.96M shares.
In the most recent transaction, Lowenthal Richard E sold 50,000 shares of SPRY for 14.49 per share on Aug 21 ’25. After the transaction, the PRESIDENT AND CEO now owns 1,196,494 company shares. In a previous transaction on Aug 21 ’25, Scott Kathleen D. sold 12,500 shares at 15.00 per share. SPRY shares that Chief Financial Officer owns now total 10,042.
Among the insiders who sold shares, Tanimoto Sarina disposed of 37,656 shares on Aug 20 ’25 at a per-share price of $14.09. This resulted in the CHIEF MEDICAL OFFICER holding 1,247,447 shares of SPRY after the transaction. In another insider transaction, Tanimoto Sarina sold 12,344 shares at $14.03 per share on Aug 19 ’25. Company shares held by the CHIEF MEDICAL OFFICER now total 1,285,103.
Despite rarely being accurate, price targets can exert some form of influence at times, and are often regarded as valuable by markets. In terms of 52-week highs and lows, SPRY has a high of $18.90 and a low of $9.97.
As of this writing, SPRY has an earnings estimate of -$0.49 per share for the current quarter. EPS was calculated based on a consensus of 5.0 estimates, with a high estimate of -$0.46 per share and a lower estimate of -$0.56. The company reported an EPS of -$0.2 in the last quarter
Balance Sheet Annually/Quarterly
As well as showing the assets and liabilities of the company, the balance sheet also shows the amount invested in equity by investors. Investors can analyze a company’s future prospects by calculating its financial ratios based on this information. SPRY’s latest balance sheet shows that the firm has $60.06M in Cash & Short Term Investments as of fiscal 2021. There were $9.03M in debt and $8.19M in liabilities at the time. Its Book Value Per Share was $1.95, while its Total Shareholder’s Equity was -$31.27M.
Analysts Opinion
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for SPRY is Buy with a score of 4.75.
